Diabetes Therapeutics Market, By Therapy Type, By Diseases, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

List of Tables

REPORT HIGHLIGHT

Diabetes Therapeutics Market size was valued at USD 65,200.1 Million in 2022, expanding at a CAGR of 5.9 % from 2023 to 2030.

Diabetes therapies encompass a diverse range of medical strategies and interventions devised for the management of diabetes mellitus, a chronic metabolic disorder characterized by elevated blood sugar levels. These therapeutic approaches are aimed at aiding individuals with diabetes in regulating their blood glucose levels, preventing complications, and ultimately improving their overall quality of life. The spectrum of diabetes treatment options includes dietary and lifestyle modifications, as well as oral medications, injectable insulin, and various pharmacological interventions.

Moreover, continuous monitoring, patient education, and active involvement are integral aspects of diabetes therapies. These elements play a pivotal role in achieving glycemic control, reducing the risk of complications, and fostering the long-term health and well-being of individuals living with diabetes.

Diabetes Therapeutics Market- Market Dynamics

Global rise in diabetes prevalence propels market demand

The escalating incidence of both type 1 and type 2 diabetes, often associated with factors such as sedentary lifestyles, unhealthy dietary habits, and obesity, has led to an increasing demand for effective therapies. The mounting number of diabetes diagnoses and related complications is placing substantial pressure on healthcare systems worldwide. In response, pharmaceutical companies and researchers are driven to develop novel treatments, including improved insulin formulations, innovative oral medications, and cutting-edge technologies such as continuous glucose monitoring and artificial pancreas systems. Addressing the diabetes epidemic has emerged as a paramount healthcare priority.

Diabetes Therapeutics Market- Key Insights

Based on the analysis provided by our research analyst, the global market for Diabetes Therapeutics is anticipated to experience an annual growth rate of approximately 5.9% over the forecast period spanning from 2023 to 2030.

The Diabetes Therapeutics industry is poised for substantial growth, largely attributed to the global increase in the prevalence of diabetes.

In terms of Therapy Type segmentation, the year 2022 witnessed Oral Antidiabetics as the dominant category.

Regarding Diseases segmentation, Gestational diabetes emerged as the leading Therapy Type in 2022.

Diabetes Therapeutics Market- Segmentation Analysis:

The Global Diabetes Therapeutics Market is structured around key parameters, including Therapy Type, Diseases, End User, and Region.

Within the Therapy Type category, the market is categorized into three primary segments: Oral Antidiabetics, Injectable Antidiabetics, and Others. Notably, the Oral Antidiabetics sector assumes a dominant position within the market. There is significant demand for oral antidiabetics in the field of diabetes therapeutics. These medications, often available in the form of pills or tablets, play a vital role in helping individuals with type 2 diabetes manage their blood sugar levels effectively. They are a cornerstone of oral treatment, contributing to glucose control and the reduction of complications.

Diabetes Therapeutics Market- Geographical Insights

The market for diabetes therapeutics spans across various regions, including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa, with each region further segmented by individual countries engaged in business activities.

Notably, there is a substantial demand for diabetes medications in the Asia-Pacific region, attributed to several converging factors. Firstly, the region is witnessing a surge in diabetes prevalence, primarily fueled by urbanization, sedentary lifestyles, and dietary shifts. These factors collectively contribute to the growing need for effective diabetes treatments in the Asia-Pacific region.

Diabetes Therapeutics Market- Competitive Landscape:

The diabetes medications market features a dynamic and competitive landscape, with major pharmaceutical giants and emerging biotech companies at the forefront. Prominent competitors in the insulin sector, including Novo Nordisk, Sanofi, and Eli Lilly, play a crucial role by developing and offering a wide range of insulin therapies, injectable GLP-1 receptor agonists, and oral diabetes medications.

Furthermore, device manufacturers like Dexcom and Medtronic contribute to this competitive environment by providing continuous glucose monitoring systems and insulin delivery devices, introducing innovative solutions to the market and enhancing the treatment options available to individuals living with diabetes.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS

Astrazeneca PLC
Boehringer Ingelheim GmbH
Eli Lilly and Company
GlaxoSmithKline PLC
Novartis AG
Novo Nordisk
Sanofi SA
Takeda Pharmaceutical Company Limited
Johnson and Johnson Md&D
Merck and Co. Inc.

GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE

Oral Antidiabetics
Injectable Antidiabetics
Others

GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES

Type 1 diabetes
Type 2 diabetes
Gestational diabetes

GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER

Hospitals and Clinics
Homecare
others

GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION

North America
The U.S.
Canada
Europe
Germany
France
Italy
Spain
United Kingdom
Russia
Netherlands
Sweden
Poland
Rest of Europe
Asia Pacific
India
China
South Korea
Japan
Australia
Thailand
Indonesia
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
United Arab Emirates
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV1798

1. Diabetes Therapeutics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. Diabetes Therapeutics Market Snippet by Diseases
- 2.1.2. Diabetes Therapeutics Market Snippet by Therapy Type
- 2.1.3. Diabetes Therapeutics Market Snippet by End User
- 2.1.4. Diabetes Therapeutics Market Snippet by Country
- 2.1.5. Diabetes Therapeutics Market Snippet by Region
2.2. Competitive Insights

3. Diabetes Therapeutics Key Market Trends

3.1. Diabetes Therapeutics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. Diabetes Therapeutics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. Diabetes Therapeutics Market Opportunities
3.4. Diabetes Therapeutics Market Future Trends

4. Diabetes Therapeutics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. Diabetes Therapeutics Market: COVID-19 Impact Analysis

5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
- 5.2.1. Top Performing Segments
- 5.2.2. Marginal Growth Segments
- 5.2.3. Top Looser Segments
- 5.2.4. Marginal Loss Segments

6. Diabetes Therapeutics Market Landscape

6.1. Diabetes Therapeutics Market Share Analysis, 2022
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. Diabetes Therapeutics Market - By Diseases

7.1. Overview
- 7.1.1. Segment Share Analysis, By Diseases, 2022 & 2030 (%)
- 7.1.2. Type 1 diabetes
- 7.1.3. Type 2 diabetes
- 7.1.4. Gestational diabetes

8. Diabetes Therapeutics Market - By Therapy Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Therapy Type, 2022 & 2030 (%)
- 8.1.2. Oral Antidiabetics
- 8.1.3. Injectable Antidiabetics
- 8.1.4. Others

9. Diabetes Therapeutics Market - By End User

9.1. Overview
- 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
- 9.1.2. Hospitals and Clinics
- 9.1.3. Homecare
- 9.1.4. others

10. Diabetes Therapeutics Market- By Geography

10.1. Introduction
- 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
10.2. North America
- 10.2.1. Overview
- 10.2.2. Diabetes Therapeutics Key Manufacturers in North America
- 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.2.4. North America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.2.5. North America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.7. U.S.
  - 10.2.7.1. Overview
  - 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.7.3. U.S. Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.2.7.4. U.S. Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.2.8. Canada
  - 10.2.8.1. Overview
  - 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.2.8.3. Canada Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.2.8.4. Canada Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.3. Europe
- 10.3.1. Overview
- 10.3.2. Diabetes Therapeutics Key Manufacturers in Europe
- 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.3.4. Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.3.5. Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.7. Germany
  - 10.3.7.1. Overview
  - 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.7.3. Germany Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.7.4. Germany Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.8. Italy
  - 10.3.8.1. Overview
  - 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.8.3. Italy Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.8.4. Italy Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.9. United Kingdom
  - 10.3.9.1. Overview
  - 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.9.3. United Kingdom Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.9.4. United Kingdom Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.10. France
  - 10.3.10.1. Overview
  - 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.10.3. France Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.10.4. France Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.11. Russia
  - 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.11.2. Russia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.11.3. Russia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.12. Netherlands
  - 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.12.2. Netherlands Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.12.3. Netherlands Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.13. Sweden
  - 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.13.2. Sweden Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.13.3. Sweden Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.14. Poland
  - 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.14.2. Poland Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.14.3. Poland Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.3.15. Rest of Europe
  - 10.3.15.1. Overview
  - 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.3.15.3. Rest of the Europe Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.4. Asia Pacific (APAC)
- 10.4.1. Overview
- 10.4.2. Diabetes Therapeutics Key Manufacturers in Asia Pacific
- 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.4.4. Asia Pacific Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.4.5. Asia Pacific Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.7. India
  - 10.4.7.1. Overview
  - 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.7.3. India Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.7.4. India Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.8. China
  - 10.4.8.1. Overview
  - 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.8.3. China Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.8.4. China Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.9. Japan
  - 10.4.9.1. Overview
  - 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.9.3. Japan Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.9.4. Japan Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.10. South Korea
  - 10.4.10.1. Overview
  - 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.10.3. South Korea Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.10.4. South Korea Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.11. Australia
  - 10.4.11.1. Overview
  - 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.11.3. Australia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.11.4. Australia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.12. Thailand
  - 10.4.12.1. Overview
  - 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.12.3. Thailand Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.12.4. Thailand Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.13. Indonesia
  - 10.4.13.1. Overview
  - 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.13.3. Indonesia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.13.4. Indonesia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.14. Philippines
  - 10.4.14.1. Overview
  - 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.14.3. Philippines Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.14.4. Philippines Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.4.15. Rest of APAC
  - 10.4.15.1. Overview
  - 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.4.15.3. Rest of APAC Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.5. Latin America
- 10.5.1. Overview
- 10.5.2. Diabetes Therapeutics Key Manufacturers in Latin America
- 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.5.4. Latin America Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.5.5. Latin America Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.7. Brazil
  - 10.5.7.1. Overview
  - 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.7.3. Brazil Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.7.4. Brazil Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.8. Mexico
  - 10.5.8.1. Overview
  - 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.8.3. Mexico Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.8.4. Mexico Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.9. Argentina
  - 10.5.9.1. Overview
  - 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.9.3. Argentina Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.9.4. Argentina Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.10. Colombia
  - 10.5.10.1. Overview
  - 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.10.3. Colombia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.10.4. Colombia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.5.11. Rest of LATAM
  - 10.5.11.1. Overview
  - 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.5.11.3. Rest of LATAM Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
10.6. Middle East and Africa
- 10.6.1. Overview
- 10.6.2. Diabetes Therapeutics Key Manufacturers in Middle East and Africa
- 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
- 10.6.4. Middle East and Africa Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
- 10.6.5. Middle East and Africa Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
- 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.7. Saudi Arabia
  - 10.6.7.1. Overview
  - 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.7.3. Saudi Arabia Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.8. United Arab Emirates
  - 10.6.8.1. Overview
  - 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.8.3. United Arab Emirates Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.9. Israel
  - 10.6.9.1. Overview
  - 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.9.3. Israel Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.9.4. Israel Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.10. Turkey
  - 10.6.10.1. Overview
  - 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.10.3. Turkey Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.10.4. Turkey Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.11. Algeria
  - 10.6.11.1. Overview
  - 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.11.3. Algeria Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.11.4. Algeria Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.12. Egypt
  - 10.6.12.1. Overview
  - 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.12.3. Egypt Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.12.4. Egypt Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
- 10.6.13. Rest of MEA
  - 10.6.13.1. Overview
  - 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
  - 10.6.13.3. Rest of MEA Market Size and Forecast, By Diseases, 2018 - 2030 (US$ Million)
  - 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapy Type, 2018 - 2030 (US$ Million)
  - 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Diabetes Therapeutics Industry

11.1. Competitive Dashboard
11.2. Company Profiles
- 11.2.1. Astrazeneca PLC
- 11.2.2. Boehringer Ingelheim GmbH
- 11.2.3. Eli Lilly and Company
- 11.2.4. GlaxoSmithKline PLC
- 11.2.5. Novartis AG
- 11.2.6. Novo Nordisk
- 11.2.7. Sanofi SA
- 11.2.8. Takeda Pharmaceutical Company Limited
- 11.2.9. Johnson and Johnson Md&D
- 11.2.10. Merck and Co. Inc.

12. 360 Degree Analyst View

13. Appendix

13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us

Product Code: ANV1798

List of Tables

TABLE List of data Therapy Types
TABLE Market drivers; Impact Analysis
TABLE Market restraints; Impact Analysis
TABLE Diabetes Therapeutics Market: Diseases Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Diseases
TABLE Global Diabetes Therapeutics Market, by Diseases 2018-2030 (USD Million)
TABLE Diabetes Therapeutics Market: Therapy Type Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Therapy Type
TABLE Global Diabetes Therapeutics Market, by Therapy Type 2018-2030 (USD Million)
TABLE Diabetes Therapeutics Market: End User Snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by End User
TABLE Global Diabetes Therapeutics Market, by End User 2018-2030 (USD Million)
TABLE Diabetes Therapeutics Market: Regional snapshot (2022)
TABLE Segment Dashboard; Definition and Scope, by Region
TABLE Global Diabetes Therapeutics Market, by Region 2018-2030 (USD Million)
TABLE North America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE North America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
TABLE North America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
TABLE North America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
TABLE Europe Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Europe Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
TABLE Europe Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Europe Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
TABLE Asia Pacific Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Asia Pacific Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
TABLE Asia Pacific Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Asia Pacific Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
TABLE Latin America Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Latin America Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
TABLE Latin America Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Latin America Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)
TABLE Middle East and Africa Diabetes Therapeutics Market, by Country, 2018-2030 (USD Million)
TABLE Middle East and Africa Diabetes Therapeutics Market, by Diseases, 2018-2030 (USD Million)
TABLE Middle East and Africa Diabetes Therapeutics Market, by Therapy Type, 2018-2030 (USD Million)
TABLE Middle East and Africa Diabetes Therapeutics Market, by End User, 2018-2030 (USD Million)

Diabetes Therapeutics Market, By Therapy Type, By Diseases, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

Description

Table of Contents

List of Tables

REPORT HIGHLIGHT

Diabetes Therapeutics Market- Segmentation Analysis:

Diabetes Therapeutics Market- Competitive Landscape:

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL DIABETES THERAPEUTICS MARKET KEY PLAYERS

GLOBAL DIABETES THERAPEUTICS MARKET, BY THERAPY TYPE

GLOBAL DIABETES THERAPEUTICS MARKET, BY DISEASES

GLOBAL DIABETES THERAPEUTICS MARKET, BY END USER

GLOBAL DIABETES THERAPEUTICS MARKET, BY REGION

Table of Contents

1. Diabetes Therapeutics Market Overview

2. Executive Summary

3. Diabetes Therapeutics Key Market Trends

4. Diabetes Therapeutics Industry Study

5. Diabetes Therapeutics Market: COVID-19 Impact Analysis

6. Diabetes Therapeutics Market Landscape

7. Diabetes Therapeutics Market - By Diseases

8. Diabetes Therapeutics Market - By Therapy Type

9. Diabetes Therapeutics Market - By End User

10. Diabetes Therapeutics Market- By Geography

11. Key Vendor Analysis- Diabetes Therapeutics Industry

12. 360 Degree Analyst View

13. Appendix

List of Tables